ABSTRACT
Background The effective reproduction number (Re) serves as a metric of population-wide, time-varying disease spread. During the COVID-19 pandemic, Re was primarily estimated from clinical surveillance data streams (Rcc), which have varied in quality and representativeness due to changes in testing volume, test-seeking behavior, and resource constraints. Deriving Re from alternative data sources such as wastewater could inform future public health responses.
Objectives We estimated county-aggregated, sewershed-restricted wastewater-based SARS-CoV-2 Re (Rww) from May 1, 2022 to April 30, 2023 for five counties in California of varying population sizes, clinical testing rates, demographics, proportions surveilled by wastewater, and sampling frequencies to validate the reliability of Rww as a real-time disease surveillance metric.
Methods We produced both instantaneous and cohort sewershed-restricted Re using smoothed and deconvolved wastewater concentrations. We then population-weighted and aggregated these sewershed-level estimates to arrive at county-level Re. Using mean absolute error (MAE), Spearman’s rank correlation (ρ), confusion matrix classification, and cross-correlation analyses, we compared the timing and trajectory of two Rww models to: (1) a publicly available, county-level ensemble of Rcc estimates, and (2) a county-aggregated, sewershed-restricted Rcc.
Results Both Rww models demonstrated high concordance with traditional Rcc estimates, as indicated by low mean absolute errors (MAE ≤ 0.09), significant positive Spearman correlation (Spearman ρ ≥ 0.66, p < 0.001), and high confusion matrix classification accuracy (≥ 0.81). The relative timings of Rwwand Rcc were less clear, with cross-correlation analyses suggesting strong associations for a wide range of temporal lags that varied by county and Rww model type.
Discussion This Re estimation methodology provides a generalizable, robust, and operationalizable framework for estimating county-level Rww. Our results support the additional use of Rwwas an epidemiological tool for surveillance. Based on this research, we produced publicly available Rww nowcasts for the California Communicable diseases Assessment Tool (https://calcat.covid19.ca.gov/cacovidmodels/).
Competing Interest Statement
The findings and conclusions in this article are those of the author(s) and do not necessarily represent the views or opinions of the California Department of Public Health or the California Health and Human Services Agency.
Funding Statement
The wastewater sampling conducted through Method 1 was supported by gifts from the CDC Foundation and the Sergey Brin Family Foundation to ABB (coauthor). Additional research support for Method 2 were provided through a philanthropic gift to the University of California, Davis. CDPH wastewater surveillance efforts are supported in part by the Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement (no. 6NU50CK000539-04-02) from CDC. No authors or affiliated institutions at any time received payment or services from a third party for any aspect of the submitted work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Committee for the Protection of Human Subjects (CPHS) of the California Health and Human Services waived ethical approval for this work. CPHS determined that our proposed project is exempt under their criteria.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All wastewater data used in this study is publicly accessible through the CA Open Data Portal at https://data.ca.gov/dataset/covid-19-wastewater-surveillance-data-california. Models contributing to the CalCAT ensemble also use data publicly accessible through the CA Open Data Portal, such as downloadable case counts, hospitalizations, deaths and test positivity (https://data.chhs.ca.gov/organization/california-department-of-public-health). Sewershed-restricted COVID-19 case data reported to CDPH is not publicly available; readers should contact the corresponding author with data requests.
https://data.ca.gov/dataset/covid-19-wastewater-surveillance-data-california
https://data.chhs.ca.gov/organization/california-department-of-public-health
